Literature DB >> 12110001

Nitric oxide down-regulates connective tissue growth factor in rat mesangial cells.

Annette Keil1, Ingrid E Blom, Roel Goldschmeding, Harald D Rupprecht.   

Abstract

BACKGROUND: Nitric oxide (NO) exerts complex regulatory actions on mesangial cell (MC) biology, such as inhibition of proliferation, adhesion or contractility and induction of apoptosis. In our previous studies the NO-donor S-nitroso-glutathione (GSNO) was found to be a potent inhibitor of MC growth. This effect was mediated at least in part by inhibitory effects of GSNO on the transcription factor early growth response gene-1 (Egr-1) [10]. We therefore were interested in the regulation of gene expression in MC after treatment with NO.
METHODS: To identify the genes that are regulated by NO in MC, gene expression was analyzed by representational difference analysis. Expression of connective tissue growth factor (CTGF) was studied by Northern and Western blot analyses.
RESULTS: Cultured rat MCs treated with GSNO for 8 hours were compared with unstimulated MCs and the CTGF mRNA was found to be down-regulated. The down-regulation was dose-dependent and transient, with a maximum inhibition seen after 6 hours. In parallel, down-regulation of CTGF protein by GSNO was observed by Western blot analysis. Other NO-donors such as S-nitroso-N-acetyl-D,L-penicillamine and spermine-NO showed similar effects. The induction of the inducible NO-synthase by TNF-alpha, IL-1beta and LPS provoked a transient down-regulation of CTGF mRNA, an effect that could be partially overcome by pretreatment with the NOS-inhibitor Nomega-nitro-l-arginine methyl ester. The observed NO-effect could be simulated by treatment with the stable cGMP analog 8br-cGMP, and was abolished by blocking the guanylyl cyclase with the inhibitor NS2028.
CONCLUSION: NO acts as a strong repressor of CTGF expression in cultured rat MC. Thus, in addition to its antiproliferative effects, NO potentially exerts antifibrotic activity by down-regulation of CTGF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110001     DOI: 10.1046/j.1523-1755.2002.00462.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat.

Authors:  Fara Sirad; Su Hlaing; Istvan Kovanecz; Jorge N Artaza; Leah A Garcia; Jacob Rajfer; Monica G Ferrini
Journal:  J Sex Med       Date:  2011-01-26       Impact factor: 3.802

Review 2.  New molecular insights in diabetic nephropathy.

Authors:  Ionel Alexandru Checheriţă; Gina Manda; Mihai Eugen Hinescu; Ileana Peride; Andrei Niculae; Ştefana Bîlha; Angelica Grămăticu; Luminiţa Voroneanu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

3.  Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.

Authors:  Sharon G Adler; Sherwyn Schwartz; Mark E Williams; Carlos Arauz-Pacheco; Warren K Bolton; Tyson Lee; Dongxia Li; Thomas B Neff; Pedro R Urquilla; K Lea Sewell
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 8.237

Review 4.  Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.

Authors:  Ali Keshavarz; Hossam Kadry; Ahmed Alobaida; Fakhrul Ahsan
Journal:  Expert Opin Drug Deliv       Date:  2020-02-19       Impact factor: 6.648

5.  Differentiated thick ascending limb (TAL) cultured cells derived from SV40 transgenic mice express functional apical NHE2 isoform: effect of nitric oxide.

Authors:  Soline Bourgeois; Patrick Rossignol; Françoise Grelac; Cécile Chalumeau; Christophe Klein; Kamel Laghmani; Régine Chambrey; Patrick Bruneval; Jean-Paul Duong; Josiane Poggioli; Pascal Houillier; Michel Paillard; Odile Kellermann; Marc Froissart
Journal:  Pflugers Arch       Date:  2003-06-26       Impact factor: 3.657

6.  Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1.

Authors:  Ellen Dreieicher; Karl-Friedrich Beck; Sandra Lazaroski; Meike Boosen; Wasiliki Tsalastra-Greul; Martina Beck; Ingrid Fleming; Liliana Schaefer; Josef Pfeilschifter
Journal:  J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 10.121

7.  Antioxidant diet and sex interact to regulate NOS isoform expression and glomerular mesangium proliferation in Zucker diabetic rat kidney.

Authors:  Yuriy Slyvka; Ramiro Malgor; Sharon R Inman; Julia Ding; Victor Heh; Felicia V Nowak
Journal:  Acta Histochem       Date:  2016-01-18       Impact factor: 2.479

8.  Proinflammatory role of leukocyte-derived Egr-1 in the development of murine postoperative ileus.

Authors:  Joachim Schmidt; Burkhard Stoffels; Beverley A Moore; R Savanh Chanthaphavong; Abigail R Mazie; Bettina M Buchholz; Anthony J Bauer
Journal:  Gastroenterology       Date:  2008-06-04       Impact factor: 22.682

Review 9.  VEGF and podocytes in diabetic nephropathy.

Authors:  Alda Tufro; Delma Veron
Journal:  Semin Nephrol       Date:  2012-07       Impact factor: 5.299

10.  Expression of nitric oxide synthase and transforming growth factor-beta in crush-injured tendon and synovium.

Authors:  Horma Darmani; James Crossan; Sarah D McLellan; Dominic Meek; Curtis Adam
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.